Explore 3 Stock Ideas & Industry Insights Download Free Report

Strata Critical Medical, Inc.

Company price
5.56 USD 0.30 ( 5.70%)
Last update at 2026-11-06T21:00:00Z
VOLUME
1354269
Market Cap
467.99M

Momentum Score

…

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
5.16
Low
5.62
High
52 Week Price Range
3.95
Low
6.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
5.26
Dividend Yield
-
Revenue TTM
255.98M
Revenue Per Share
3.02
Gross Profit TTM
54.40M
Debt / Equity
0.01
ROE
-9.22%
Net Debt
-27.66M
ROCE
-4.12%
Diluted EPS TTM
-0.28

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -20.07M -27.56M -57.54M -28.03M -43.70M
Net income 41.35M -27.31M -56.08M -27.26M -40.05M
Selling general administrative 60.88M 81.71M 95.17M 62.51M 30.14M
Selling and marketing expenses - 7.95M 10.44M 7.75M 2.79M
Gross profit 41.13M 58.92M 42.12M 22.27M 10.52M
Reconciled depreciation 8.19M 5.96M 7.11M 5.72M 0.60M
Ebit -12.61M -27.56M -57.54M -28.03M -43.70M
Ebitda -5.71M -21.60M -50.43M -22.31M -43.10M
Depreciation and amortization 6.90M 5.96M 7.11M 5.72M 0.60M
Operating income -22.35M -33.93M -68.12M -53.53M -24.09M
Other operating expenses 219.49M 282.62M 293.30M 199.65M 74.62M
Tax provision 0.00M -0.26M -1.47M -0.77M -3.64M
Interest income 4.24M 7.21M 8.44M 3.43M 0.46M
Net interest income 4.24M 7.21M 8.44M 3.43M 0.46M
Income tax expense -61.41M -0.26M -1.47M -0.77M -3.64M
Total revenue 197.14M 248.69M 225.18M 146.12M 50.53M
Total operating expenses 63.48M 92.84M 110.24M 75.80M 34.61M
Cost of revenue 156.01M 189.77M 183.06M 123.84M 40.01M
Total other income expense net 2.29M 6.36M 10.57M 25.50M -19.60M
Net income from continuing ops -20.07M -27.31M -56.08M -27.26M -40.05M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 325.47M 256.68M 294.94M 325.02M 335.88M
Intangible assets 47.50M 13.65M 20.52M 46.37M 24.42M
Other current assets 25.00M 12.02M 19.12M 15.17M 6.88M
Total liab 46.40M 34.74M 60.64M 50.54M 44.51M
Total stockholder equity 279.07M 221.94M 234.30M 274.49M 291.37M
Other current liab 19.14M 12.77M 23.86M 6.71M 5.98M
Common stock 0.01M 0.01M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings -145.55M -186.90M -159.75M -103.68M -76.42M
Good will 88.21M 41.05M 40.37M 39.45M 13.33M
Cash 30.97M 18.38M 27.87M 41.34M 2.60M
Total current liabilities 19.79M 22.73M 35.49M 26.61M 12.78M
Current deferred revenue - 6.66M 6.84M 6.71M 5.98M
Net debt -27.66M -9.06M -3.35M -23.01M -1.88M
Short term debt 0.65M 3.30M 4.79M 3.36M 0.44M
Short long term debt total 3.31M 9.32M 24.52M 18.33M 0.72M
Other stockholder equity 424.62M 407.08M 390.08M 375.87M 368.68M
Total current assets 126.19M 160.74M 206.26M 218.13M 294.94M
Long term investments - - - 0.39M 0.20M
Short term investments 30.26M 108.76M 138.26M 150.74M 279.37M
Net receivables 39.96M 21.59M 21.00M 10.88M 5.55M
Inventory - - - 1.13M 0.55M
Accounts payable 19.14M - - 16.54M 6.37M
Accumulated other comprehensive income - 1.75M 3.96M 2.29M -0.90M
Non currrent assets other 24.02M 1.44M 1.40M 1.36M 0.23M
Non current assets total 199.28M 95.93M 88.68M 106.90M 40.94M
Capital lease obligations 3.31M 9.32M 24.52M 18.33M 0.72M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 150.10M -1.02M 17.09M 79.34M -321.34M
Total cashflows from investing activities 69.75M -1.02M 17.09M 79.34M -321.34M
Net borrowings - - - 0.00M -1.17M
Total cash from financing activities -8.91M -5.76M -0.08M -1.08M 332.26M
Net income 41.35M -27.31M -56.08M -27.26M -40.05M
Change in cash 11.59M -9.37M -15.40M 36.84M -4.69M
Begin period cash flow 19.65M 29.02M 44.42M 7.58M 12.28M
End period cash flow 31.23M 19.65M 29.02M 44.42M 7.58M
Total cash from operating activities -48.91M -2.52M -32.35M -37.13M -15.62M
Issuance of capital stock - - - 0.00M 119.63M
Depreciation 8.19M 5.96M 7.11M 5.72M 0.60M
Other cashflows from investing activities -1.42M -2.11M 0.14M - -0.50M
Change to account receivables -12.03M -1.00M -10.25M -5.35M -0.41M
Sale purchase of stock 0.00M -0.24M 0.00M - -
Other cashflows from financing activities -9.11M -5.51M -0.15M -1.17M 333.28M
Capital expenditures 11.01M 32.99M 2.11M 0.73M 0.30M
Change in working capital -9.08M -3.01M -6.74M -0.02M -2.20M
Stock based compensation 17.83M 19.89M 12.50M 8.28M 9.62M
Other non cash items -107.63M 2.20M 12.32M -23.08M 20.06M
Free cash flow -59.92M -35.51M -34.46M -37.86M -15.91M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SRTA
Strata Critical Medical, Inc.
0.30
5.70%
5.56 - 138.89 1.83 1.70 1.78 -9.95
HCA
HCA Healthcare, Inc.
-12.49
2.46%
494.99 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation
-3.13
1.09%
283.33 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR
0.06
0.42%
14.62 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
-
-%
5.28 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

Strata Critical Medical, Inc.

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

666 Third Avenue, New York, NY, United States, 10017

(917) 781-3190

327

Name Title Year Born
Ms. Melissa M. Tomkiel J.D. Co- CEO, General Counsel, Corporate Secretary & Director 1981
Mr. William A. Heyburn Co-CEO, CFO & Director 1989
Mr. Amir M. Cohen Chief Accounting & Integration Officer 1977
Mr. Scott M. Wunsch Chief Executive Officer of Logistics Services 1977
Mr. Mathew Schneider C.F.A. CFO of Clinical Services & VP of Finance and Investor Relations NA
Mr. Keith Trepanier Chief of Safety NA
Mr. Louis R. Verdetto Chief Executive Officer of Clinical Services 1984
Dr. Scott Silvestry Chief Medical Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…